JW Holdings Corporation (KRX:096760)

Market Cap	271.57B +24.5%
Revenue (ttm)	969.57B +9.2%
Net Income	58.50B -6.6%
EPS	841.00 -3.8%
Shares Out	69.19M
PE Ratio	4.67
Forward PE	n/a
Dividend	155.00 (3.76%)
Ex-Dividend Date	Mar 31, 2026

Volume	68,360
Average Volume	125,128
Open	3,955.00
Previous Close	3,925.00
Day's Range	3,955.00 - 4,090.00
52-Week Range	2,880.00 - 4,495.00
Beta	0.68
RSI	44.48
Earnings Date	Apr 2, 2026

About JW Holdings

JW Holdings Corporation, together with its subsidiaries, operates as a healthcare company in South Korea, the United States, Japan, China, and internationally. The company offers amino acid solutions, gastrointestinal agents, wound care, eye care, liver disease treatment, cold medicine, API, oral and topical analgesic, and other miscellaneous pharmaceutical products. It also offers hairdye, hair care, beauty care, and other cosmetics products; infant care system, gynecological examining table, sterilizer equipment, diagnostic imaging equipment,...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1945
• Employees: 127
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 096760

Financial Performance

In 2025, JW Holdings's revenue was 969.57 billion, an increase of 9.22% compared to the previous year's 887.71 billion. Earnings were 58.50 billion, a decrease of -6.57%.